Glaucoma Consultants & Cente is categorized under Business Consultants in Charleston, SC and active since 2003.
Glaucoma Consultants & Cente was established in 2003, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Kenneth Sharpe at the company’s single location by writing to 9229 University Boulevard B, Charleston, South Carolina SC 29406 or by phoning (732) 207-0286. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Glaucoma Consultants & Cente |
| Contact Person: | Kenneth Sharpe |
| Address: | 9229 University Boulevard B, Charleston, South Carolina 29406 |
| Phone Number: | (732) 207-0286 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Glaucoma Consultants & Cente was started in 2003 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Kenneth Sharpe for inquiries that concern Glaucoma Consultants & Cente by calling the company number (732) 207-0286, as your correspondence is most welcome. Additionally, the physical location of the single location of Glaucoma Consultants & Cente can be found at the coordinates as well as the street address 9229 University Boulevard B in Charleston, South Carolina 29406.
For its online presence, you may visit Glaucoma Consultants & Cente’s website at and engage with its social media outlets through on Twitter and on Facebook.